2023 Lunch and Learn Series
Registration is now open for the Consortium’s 2023 provider Lunch and Learn series. Click on the hyperlinked topics below to learn more and register for a session on the Colorado Medical Society’s registration page. Each talk has been approved for up to 1 AMA PRA Category 1 credits. Additional details regarding credit can be found on the topic page.
Please check this page for updates as we continue to make additions to the schedule throughout the year. Most Lunch and Learns will be recorded. If a recording is available, it will be linked below once each webinar is complete.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Colorado Medical Society and North Colorado Health Alliance. The Colorado Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
| Date | Provider Lunch and Learn Series Topic | Speaker(s) |
| Wed., Jan. 11 | 2022 CDC Opioid Guidelines: What Clinicians Need to Know | Joshua Blum, MD |
| Wed., Jan. 18 | Let’s Talk About LIFE: Musings From a Doc and a Harm Reductionist | Sarah Axelrath, MD Lisa Raville |
| Wed., Jan. 25 | Women’s Path to Wellness | LaTisha Bader, PhD |
| Wed., Feb. 1 | Pearls and Updates in Perinatal Addiction Care **this session was not recorded | Kaylin Klie, MD |
| Wed., Feb. 8 | Navigating the Psychedelic Landscape in Colorado: Public Policy and Implications for Clinical Practice | Jonathan Treem, MD |
| Wed., Feb. 15 | No session | — |
| Wed. Feb., 22 | Updates and Drug Trends from the DEA Perspective **this session was not recorded | Aminta Bhutani |
| Wed., March 1 | No session | — |
| Wed., March 8 | Motivational Interviewing | Adam Musielewicz, MPA, BA, CNM |
| Wed., March 15 | Community Drug Checking & Novel Psychoactive Substances | Nabarun Dasgupta, PhD & Colin Miller |
| Wed., March 22 | Screening Tools for Primary Care Settings | Kevin Hughes, CAC II |
| Wed., March 29 | Benzodiazepine Induced Neurological Dysfunction | Alexis Ritvo, MD & D. Foster |